MedTrace Logo

Enhanced Recovery for Patients Undergoing Radical Cystectomy.

NCT05210673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-02-11

No results posted yet for this study

Summary

Investigators hypothesize that with the use of enhanced recovery of surgery (ERAS), the postoperative hospital stay after radical cystectomy is reduced, and also postoperative complications are decreased.

Conditions

  • Post Procedural Discharge

Interventions

OTHER

ERAS

Preoperative: Preoperative explanation of ERAS. Preoperative medical optimization. Smoking cessation 4-8 weeks before surgery. Nutritional status assessment. Preoperative fasting: 2hours for Clear fluids and water, 6hours for Semi-solid foods and 8 hours for Solid food. Preoperative carbohydrate loading. Pre-anesthetic medication: Avoid long active sedatives. Thromboembolic prophylaxis and Compression stockings Intraoperative: Antimicrobial prophylaxis and skin preparation. Epidural analgesia. Prevention of intraoperative hypothermia. Intraoperative fluid management. Minimize incision. Drain strategy Postoperative: Nasogastric intubation. Early oral intake. Early mobilization. Prevention of postoperative ileus through. Prevention of postoperative nausea and vomiting. Multimodal opioid sparing analgesia. Discharge criteria: Patients have resumed adequate oral intake and normal bowel function, Effective oral pain management and No other clinical or biochemical concerns

OTHER

Non ERAS pathway

standard preoperative preparation intraoperative: combined general and epidural anesthesia postoperative standard care

Sponsors & Collaborators

  • Ezzeldin Saleh Ibrahim

    collaborator UNKNOWN

  • asmaa mohamed hamza

    collaborator UNKNOWN

  • asmaa ibrahim mohamed

    collaborator UNKNOWN

  • mohamed marzouk abdallah

    collaborator UNKNOWN

  • Menoufia University

    lead OTHER

Principal Investigators

  • ashraf M eskandr · menoufia faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05210673 on ClinicalTrials.gov